Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 465

1.

High occupational level is associated with poor response to the treatment of depression: A replication study.

Mandelli L, Serretti A, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J.

Eur Neuropsychopharmacol. 2019 Mar;29(3):349-355. doi: 10.1016/j.euroneuro.2019.01.107. Epub 2019 Jan 28.

PMID:
30704794
2.

Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.

Dold M, Bartova L, Kautzky A, Porcelli S, Montgomery S, Zohar J, Mendlewicz J, Souery D, Serretti A, Kasper S.

J Clin Psychiatry. 2019 Jan 15;80(1). pii: 17m12090. doi: 10.4088/JCP.17m12090.

PMID:
30677267
3.

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.

Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis CM, Mendlewicz J, Serretti A.

Br J Psychiatry. 2019 Jan;214(1):36-41. doi: 10.1192/bjp.2018.256. Epub 2018 Nov 23.

PMID:
30468137
4.

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.

Dold M, Bartova L, Kautzky A, Serretti A, Porcelli S, Souery D, Mendlewicz J, Montgomery S, Zohar J, Kasper S.

Eur Neuropsychopharmacol. 2018 Dec;28(12):1305-1313. doi: 10.1016/j.euroneuro.2018.10.003. Epub 2018 Nov 13.

PMID:
30446357
5.

The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants.

Calabrò M, Fabbri C, Crisafulli C, Albani D, Forloni G, Kasper S, Sidoti A, Velardi E, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.

Hum Psychopharmacol. 2018 Nov;33(6):e2682. doi: 10.1002/hup.2682. Epub 2018 Nov 13. No abstract available.

PMID:
30426571
6.

Opinion paper: poor response to treatment of depression in people in high occupational levels.

Mandelli L, Serretti A, Porcelli S, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J.

Psychol Med. 2019 Jan;49(1):49-54. doi: 10.1017/S003329171800288X. Epub 2018 Oct 12.

PMID:
30311597
7.

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.

Kautzky A, Dold M, Bartova L, Spies M, Kranz GS, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Dikeos D, Rujescu D, Kasper S.

Acta Psychiatr Scand. 2019 Jan;139(1):78-88. doi: 10.1111/acps.12959. Epub 2018 Oct 5.

PMID:
30291625
8.

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, Fabbri C, Mendlewicz J, Racagni G, Kasper S, Riva MA, Drago F.

Pharmacol Rev. 2018 Jul;70(3):475-504. doi: 10.1124/pr.117.014977. Review.

PMID:
29884653
9.

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).

Dold M, Bartova L, Fugger G, Kautzky A, Souery D, Mendlewicz J, Papadimitriou GN, Dikeos D, Ferentinos P, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

Int J Neuropsychopharmacol. 2018 Jun 1;21(6):539-549. doi: 10.1093/ijnp/pyy009.

10.

Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD).

Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S.

Eur Neuropsychopharmacol. 2018 Jun;28(6):752-760. doi: 10.1016/j.euroneuro.2018.03.011. Epub 2018 Apr 26.

PMID:
29705022
11.

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives.

Fabbri C, Corponi F, Souery D, Kasper S, Montgomery S, Zohar J, Rujescu D, Mendlewicz J, Serretti A.

Int J Neuropsychopharmacol. 2019 Feb 1;22(2):93-104. doi: 10.1093/ijnp/pyy024.

12.

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.

Dold M, Bartova L, Mendlewicz J, Souery D, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

Acta Psychiatr Scand. 2018 May;137(5):401-412. doi: 10.1111/acps.12870. Epub 2018 Feb 28.

13.

Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.

Olgiati P, Serretti A, Souery D, Dold M, Kasper S, Montgomery S, Zohar J, Mendlewicz J.

J Affect Disord. 2018 Feb;227:777-786. doi: 10.1016/j.jad.2017.11.004. Epub 2017 Nov 10.

PMID:
29254066
14.

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

Kautzky A, Dold M, Bartova L, Spies M, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Kasper S.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 16m11385. doi: 10.4088/JCP.16m11385.

PMID:
29228516
15.

Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.

Dold M, Bartova L, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

J Affect Disord. 2018 Feb;227:254-259. doi: 10.1016/j.jad.2017.10.033. Epub 2017 Oct 28.

PMID:
29107818
16.

Molecular changes associated with escitalopram response in a stress-based model of depression.

Benatti C, Alboni S, Blom JMC, Mendlewicz J, Tascedda F, Brunello N.

Psychoneuroendocrinology. 2018 Jan;87:74-82. doi: 10.1016/j.psyneuen.2017.10.011. Epub 2017 Oct 13.

PMID:
29049934
17.

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.

Fabbri C, Corponi F, Albani D, Raimondi I, Forloni G, Schruers K, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Cristalli CP, Mantovani V, Mendlewicz J, Serretti A.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:203-210. doi: 10.1016/j.pnpbp.2017.10.005. Epub 2017 Oct 6.

PMID:
28989100
18.

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.

Schosser A, Carlberg L, Calati R, Serretti A, Massat I, Spindelegger C, Linotte S, Mendlewicz J, Souery D, Zohar J, Montgomery S, Kasper S.

Int J Neuropsychopharmacol. 2017 Oct 1;20(10):782-787. doi: 10.1093/ijnp/pyx028.

19.

The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.

Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2017 Jul;27(7):625-632. doi: 10.1016/j.euroneuro.2017.05.004. Epub 2017 May 31.

PMID:
28579072
20.

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.

Dold M, Bartova L, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

J Psychiatr Res. 2017 Aug;91:1-13. doi: 10.1016/j.jpsychires.2017.02.020. Epub 2017 Feb 27.

PMID:
28284107
21.

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.

Fabbri C, Crisafulli C, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.

Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):723-735. doi: 10.1007/s00406-017-0766-1. Epub 2017 Mar 4.

PMID:
28260126
22.

Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics.

Giegling I, Hosak L, Mössner R, Serretti A, Bellivier F, Claes S, Collier DA, Corrales A, DeLisi LE, Gallo C, Gill M, Kennedy JL, Leboyer M, Maier W, Marquez M, Massat I, Mors O, Muglia P, Nöthen MM, Ospina-Duque J, Owen MJ, Propping P, Shi Y, St Clair D, Thibaut F, Cichon S, Mendlewicz J, O'Donovan MC, Rujescu D.

World J Biol Psychiatry. 2017 Oct;18(7):492-505. doi: 10.1080/15622975.2016.1268715. Epub 2017 Jan 23. Review.

PMID:
28112043
23.

A New Prediction Model for Evaluating Treatment-Resistant Depression.

Kautzky A, Baldinger-Melich P, Kranz GS, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S.

J Clin Psychiatry. 2017 Feb;78(2):215-222. doi: 10.4088/JCP.15m10381.

PMID:
28068461
24.

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study.

Dold M, Kautzky A, Bartova L, Rabl U, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2016 Dec;26(12):1960-1971. doi: 10.1016/j.euroneuro.2016.10.005. Epub 2016 Nov 2.

PMID:
27816317
25.

Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response.

Fabbri C, Hosak L, Mössner R, Giegling I, Mandelli L, Bellivier F, Claes S, Collier DA, Corrales A, Delisi LE, Gallo C, Gill M, Kennedy JL, Leboyer M, Lisoway A, Maier W, Marquez M, Massat I, Mors O, Muglia P, Nöthen MM, O'Donovan MC, Ospina-Duque J, Propping P, Shi Y, St Clair D, Thibaut F, Cichon S, Mendlewicz J, Rujescu D, Serretti A.

World J Biol Psychiatry. 2017 Feb;18(1):5-28. doi: 10.1080/15622975.2016.1208843. Epub 2016 Sep 7. Review.

PMID:
27603714
26.

Bipolar II disorder as a risk factor for postpartum depression.

Mandelli L, Souery D, Bartova L, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A.

J Affect Disord. 2016 Nov 1;204:54-8. doi: 10.1016/j.jad.2016.06.025. Epub 2016 Jun 14.

PMID:
27327115
27.

High occupational level is associated with poor response to treatment of depression.

Mandelli L, Serretti A, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J.

Eur Neuropsychopharmacol. 2016 Aug;26(8):1320-6. doi: 10.1016/j.euroneuro.2016.05.002. Epub 2016 Jul 7.

PMID:
27211903
28.

Clinical and genetic factors associated with suicide in mood disorder patients.

Antypa N, Souery D, Tomasini M, Albani D, Fusco F, Mendlewicz J, Serretti A.

Eur Arch Psychiatry Clin Neurosci. 2016 Mar;266(2):181-93. doi: 10.1007/s00406-015-0658-1. Epub 2015 Dec 1.

PMID:
26626456
29.

The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.

Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S.

Int Clin Psychopharmacol. 2016 Jan;31(1):1-7. doi: 10.1097/YIC.0000000000000101.

PMID:
26544898
30.

Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study.

Balestri M, Calati R, Souery D, Kautzky A, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A.

J Affect Disord. 2016 Jan 1;189:224-32. doi: 10.1016/j.jad.2015.09.033. Epub 2015 Sep 30.

PMID:
26451508
31.

Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression.

Zaninotto L, Souery D, Calati R, Di Nicola M, Montgomery S, Kasper S, Zohar J, Mendlewicz J, Robert Cloninger C, Serretti A, Janiri L.

J Affect Disord. 2015 Sep 15;184:51-9. doi: 10.1016/j.jad.2015.05.036. Epub 2015 May 28.

PMID:
26070046
32.

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample.

Zaninotto L, Souery D, Calati R, Camardese G, Janiri L, Montgomery S, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Serretti A.

Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):48-52. doi: 10.9758/cpn.2015.13.1.48.

33.

Neuronal cell adhesion genes and antidepressant response in three independent samples.

Fabbri C, Crisafulli C, Gurwitz D, Stingl J, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Girolamo GD, Serretti A.

Pharmacogenomics J. 2015 Dec;15(6):538-48. doi: 10.1038/tpj.2015.15. Epub 2015 Apr 7.

PMID:
25850031
34.

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.

Kautzky A, Baldinger P, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S.

Eur Neuropsychopharmacol. 2015 Apr;25(4):441-53. doi: 10.1016/j.euroneuro.2015.01.001. Epub 2015 Feb 2.

PMID:
25769916
35.

Familiality and SNP heritability of age at onset and episodicity in major depressive disorder.

Ferentinos P, Koukounari A, Power R, Rivera M, Uher R, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Ising M, Maier W, Mors O, Rietschel M, Preisig M, Binder EB, Aitchison KJ, Mendlewicz J, Souery D, Hauser J, Henigsberg N, Breen G, Craig IW, Farmer AE, Müller-Myhsok B, McGuffin P, Lewis CM.

Psychol Med. 2015 Jul;45(10):2215-25. doi: 10.1017/S0033291715000215. Epub 2015 Feb 20.

36.

What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram.

Souery D, Calati R, Papageorgiou K, Juven-Wetzler A, Gailledreau J, Modavi D, Sentissi O, Pitchot W, Papadimitriou GN, Dikeos D, Montgomery S, Kasper S, Zohar J, Serretti A, Mendlewicz J.

World J Biol Psychiatry. 2015 Oct;16(7):472-82. doi: 10.3109/15622975.2014.987814. Epub 2014 Dec 23.

37.

Mixed, melancholic, and anxious features in depression: a cross-sectional study of sociodemographic and clinical correlates.

Zaninotto L, Souery D, Calati R, Scudellari P, Janiri L, Montgomery S, Kasper S, Zohar J, Mendlewicz J, Serretti A.

Ann Clin Psychiatry. 2014 Nov;26(4):243-53.

PMID:
25166487
38.

Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients.

Fabbri C, Souery D, Calati R, Crisafulli C, Chierchia A, Albani D, Forloni G, Chiesa A, Martines R, Sentissi O, Mendlewicz J, De Girolamo G, Serretti A.

J Neural Transm (Vienna). 2015 Jan;122(1):43-58. doi: 10.1007/s00702-014-1290-3. Epub 2014 Aug 17.

PMID:
25129258
39.

Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression.

Benatti C, Alboni S, Blom JM, Gandolfi F, Mendlewicz J, Brunello N, Tascedda F.

Behav Brain Res. 2014 Oct 1;272:121-30. doi: 10.1016/j.bbr.2014.06.040. Epub 2014 Jun 27.

PMID:
24978096
40.

Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.

Carlberg L, Schosser A, Calati R, Serretti A, Massat I, Papageorgiou K, Kocabas NA, Mendlewicz J, Zohar J, Montgomery SA, Souery D, Kasper S.

Int J Neurosci. 2015 May;125(5):336-43. doi: 10.3109/00207454.2014.936554. Epub 2014 Jul 30.

PMID:
24955721
41.

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway.

Fabbri C, Marsano A, Albani D, Chierchia A, Calati R, Drago A, Crisafulli C, Calabrò M, Kasper S, Lanzenberger R, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.

Pharmacogenomics J. 2014 Oct;14(5):463-72. doi: 10.1038/tpj.2014.15. Epub 2014 Apr 8.

PMID:
24709691
42.

Family history of major depression and residual symptoms in responder and non-responder depressed patients.

Serretti A, Chiesa A, Calati R, Sentissi O, Akimova E, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Amital D, Montgomery S, Souery D.

Compr Psychiatry. 2014 Jan;55(1):51-5. doi: 10.1016/j.comppsych.2013.08.002. Epub 2013 Oct 21.

PMID:
24156872
43.

Social adjustment among treatment responder patients with mood disorders.

Serretti A, Chiesa A, Souery D, Calati R, Sentissi O, Kasper S, Akimova E, Marsano A, Balestri M, Alberti S, Zohar J, Amital D, Montgomery S, Mendlewicz J.

J Affect Disord. 2013 Sep 25;150(3):961-6. doi: 10.1016/j.jad.2013.05.021. Epub 2013 Jun 10.

PMID:
23764379
44.

Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features.

Zaninotto L, Souery D, Calati R, Sentissi O, Kasper S, Akimova E, Zohar J, Montgomery S, Mendlewicz J, Serretti A.

Ann Clin Psychiatry. 2013 May;25(2):97-106.

PMID:
23638440
45.

Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples.

Serretti A, Chiesa A, Calati R, Fabbri C, Sentissi O, De Ronchi D, Mendlewicz J, Souery D.

J Psychopharmacol. 2013 Jul;27(7):616-28. doi: 10.1177/0269881113485143. Epub 2013 Apr 24.

PMID:
23616438
46.

Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients.

Antypa N, Calati R, Souery D, Pellegrini S, Sentissi O, Amital D, Moser U, Montgomery S, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Serretti A.

J Affect Disord. 2013 Sep 5;150(2):649-52. doi: 10.1016/j.jad.2013.02.036. Epub 2013 Mar 26.

PMID:
23537781
47.

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.

Calati R, Crisafulli C, Balestri M, Serretti A, Spina E, Calabrò M, Sidoti A, Albani D, Massat I, Höfer P, Amital D, Juven-Wetzler A, Kasper S, Zohar J, Souery D, Montgomery S, Mendlewicz J.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:271-8. doi: 10.1016/j.pnpbp.2013.03.005. Epub 2013 Mar 26.

PMID:
23537502
48.

The impact of adverse life events on clinical features and interaction with gene variants in mood disorder patients.

Serretti A, Souery D, Antypa N, Calati R, Sentissi O, Amital D, Moser U, Kasper S, Zohar J, Mendlewicz J.

Psychopathology. 2013;46(6):384-9. doi: 10.1159/000345358. Epub 2013 Feb 13.

PMID:
23407025
49.

Working memory-related functional brain patterns in never medicated children with ADHD.

Massat I, Slama H, Kavec M, Linotte S, Mary A, Baleriaux D, Metens T, Mendlewicz J, Peigneux P.

PLoS One. 2012;7(11):e49392. doi: 10.1371/journal.pone.0049392. Epub 2012 Nov 14.

50.

Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder.

Amital D, Fostick L, Silberman A, Calati R, Spindelegger C, Serretti A, Juven-Wetzler A, Souery D, Mendlewicz J, Montgomery S, Kasper S, Zohar J.

Eur Neuropsychopharmacol. 2013 Aug;23(8):895-901. doi: 10.1016/j.euroneuro.2012.09.002. Epub 2012 Oct 31.

PMID:
23121858

Supplemental Content

Loading ...
Support Center